Skip to main navigation Skip to search Skip to main content

Impact of pharmacist intervention on electrocardiogram monitoring of pediatric patients on multiple QTc interval–prolonging medications

  • Johns Hopkins University
  • Alfred I. duPont Hospital for Children

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

OBJECTIVES To determine whether dedicated pharmacy services improve the rate of electrocardiogram (ECG) monitoring in patients at risk for medication-induced QTc interval prolongation. In addition, determine how pediatric institutions currently monitor patients at risk for medication-induced QTc interval prolongation. METHODS A pharmacist-driven monitoring protocol to detect medication-induced QTc interval prolongation was developed using published literature. If patients were prescribed 3 or more medications known to prolong the QTc interval, they were recommended to have a baseline ECG to assess the QTc interval. If 3 or more QTc interval–prolonging medications were administered for 5 or more days, a follow-up ECG was recommended. Patients prescribed medications known to prolong the QTc interval were identified. Prior to pharmacist intervention, electronic medical records were reviewed to determine if baseline and follow-up ECGs were obtained in patients meeting criteria for monitoring. A dedicated pharmacist then prospectively reviewed charts and recommended monitoring. The rate of monitoring during the intervention and baseline period was compared. To determine current practice at pediatric institutions, a survey was distributed to pharmacists. RESULTS Pharmacist intervention improved the rate of ECG monitoring in patients at risk for medication-induced QTc interval prolongation from 47.8% to 100% (p = 0.0009). Of the 55 survey participants, 6 stated their institution had QTc interval monitoring procedures in place, 35 did not have any, and 3 had procedures in process. CONCLUSIONS Targeted pharmacist intervention improved the rate of ECG monitoring in patients at risk for medication-induced prolonged QTc interval. Our research and survey data reveal that institutions could benefit from targeted pharmacist intervention to monitor patients for medication-induced QTc interval prolongation.

Original languageEnglish
Pages (from-to)399-405
Number of pages7
JournalJournal of Pediatric Pharmacology and Therapeutics
Volume22
Issue number6
DOIs
StatePublished - 1 Nov 2017

Keywords

  • Adverse effect
  • Medication interactions
  • Pediatrics
  • Pharmacist intervention
  • QTc interval
  • Torsade de pointes

Fingerprint

Dive into the research topics of 'Impact of pharmacist intervention on electrocardiogram monitoring of pediatric patients on multiple QTc interval–prolonging medications'. Together they form a unique fingerprint.

Cite this